HealthReported
AstraZeneca's Tozorakimab Shows Positive Results in Two Late-Stage COPD Trials
Full data from late-stage studies reinforce hopes the drug could become a major treatment for chronic obstructive pulmonary disease, according to CNBC.
· 1 min read